Tom Vanden Berghe



  1. Vanden Berghe T, Hoste E. Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids. Cell Death Differ. 2019;26:83-98 pubmed publisher
    ..Ultimately, we may be able to offer precision therapies specifically designed to target the molecular set-up of an individual patient, as has begun to be done in cancer therapeutics. ..
  2. Vanden Berghe T, Hassannia B, Vandenabeele P. An outline of necrosome triggers. Cell Mol Life Sci. 2016;73:2137-52 pubmed publisher
    ..The availability of new phospho-specific antibodies, pharmacologic inhibitors, and transgenic models will allow us to further document the role of necroptosis in degenerative, inflammatory and infectious diseases. ..
  3. Vanden Berghe T, Hulpiau P, Martens L, Vandenbroucke R, Van Wonterghem E, Perry S, et al. Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice. Immunity. 2015;43:200-9 pubmed publisher